Phosphonic Acid

Phosphonic Acid

SCHEMBL2399823

CCCCCCCCCCCc1ccccc1.O=[PH](O)O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.59
▸ CETP P11597 1/20 0.56
▸ ALDH1A1 P00352 3/20 0.55
▸ ESR1 P03372 2/20 0.55
▸ ADRA2A P08913 2/20 0.55
▸ ADORA3 P0DMS8 2/20 0.55
▸ TACR2 P21452 2/20 0.55
▸ SLC6A2 P23975 2/20 0.55
▸ SLC6A4 P31645 2/20 0.55
▸ SLC6A3 Q01959 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ SHBG P04278 1/20 0.55
▸ TP53 P04637 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ HSPD1 P10809 1/20 0.55
▸ ADRB3 P13945 1/20 0.55
▸ HTR2C P28335 1/20 0.55
▸ HSPE1 P61604 1/20 0.55
▸ HIF1A Q16665 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphonic Acid SCHEMBL5600656 1.00 KCNH2 (0.59) KCNH2CETPALDH1A1ESR1ADRA2A
Phosphonic Acid SCHEMBL22344800 1.00 KCNH2 (0.59) KCNH2CETPALDH1A1ESR1ADRA2A
Phosphonic Acid SCHEMBL5601960 1.00 KCNH2 (0.59) KCNH2CETPALDH1A1ESR1ADRA2A
Butylbenzyl SCHEMBL27775862 0.92 HPGD (0.55) KCNH2CETPALDH1A1ADRA2ASLC6A2
SCHEMBL2806711 0.90 KCNH2 (0.69) KCNH2CETPALDH1A1ESR1ADRA2A
Hydrogen Peroxide SCHEMBL15515419 0.90 KCNH2 (0.69) KCNH2CETPALDH1A1ESR1ADRA2A
Phosphonic Acid SCHEMBL4601781 0.90 RARB (0.64) ALDH1A1ESR1ADRA2AADORA3TACR2
Bicarbonate SCHEMBL20791912 0.88 ALDH1A1 (0.63) KCNH2CETPALDH1A1ESR1ADRA2A
Bicarbonate SCHEMBL3086181 0.88 ALDH1A1 (0.63) KCNH2CETPALDH1A1ESR1ADRA2A
Bicarbonate SCHEMBL27383089 0.88 ALDH1A1 (0.63) KCNH2CETPALDH1A1ESR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110295029-A1 NANOPARTICLE DISPERSIONS WITH LOW AGGREGATION LEVELS LUCENT TECHNOLOGIES, INC. (US) 2011-12-01 — — US disclosed
US-8012564-B2 Nanoparticle dispersions with low aggregation levels ALCATEL LUCENT (FR) 2011-09-06 — — US disclosed
US-20080017848-A1 NANOPARTICLE DISPERSIONS WITH LOW AGGREGATION LEVELS LUCENT TECHNOLOGIES (US) 2008-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295029-A1 NANOPARTICLE DISPERSIONS WITH LOW AGGREGATION LEVELS CCNO, FLOT1, TSPO KCNH2 2471/4885CETP 816/4885ALDH1A1 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback